tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Prakhar Agrawal, 48 are a BUY (94.12%), 3 are a HOLD (5.88%).
Analyst Prakhar Agrawal, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 42.94% that have a potential upside of 57.81% achieved within 159 days.
Prakhar Agrawal’s has documented 93 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AKRO, Akero Therapeutics at 10-Dec-2025.
Analyst best performing recommendations are on NEXI (NEXIMMUNE).
The best stock recommendation documented was for DICE (DICE MOLECULES HOLDINGS LLC) at 9/14/2022. The price target of $36 was fulfilled within 27 days with a profit of $16.39 (83.58%) receiving and performance score of 30.96.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 09-Feb-2022
$100
$0.01 (0.01%)
$120
3 years 11 months 9 days ago
(09-Feb-2022)
3/5 (60%)
$6.56 (7.02%)
256
Hold
Since 22-Dec-2021
$100
4 years 22 days ago
(27-Dec-2021)
4/6 (66.67%)
$9.27 (10.22%)
204
Hold
Since 15-Dec-2021
$100
$0.01 (0.01%)
$104
4 years 1 months 3 days ago
(15-Dec-2021)
0/2 (0%)
$7.15 (7.70%)
Hold
Since 15-Dec-2021
$100
$0.01 (0.01%)
4 years 1 months 3 days ago
(15-Dec-2021)
3/4 (75%)
$7.15 (7.70%)
557
Hold
Since 15-Dec-2021
$100
$0.01 (0.01%)
$76
4 years 1 months 3 days ago
(15-Dec-2021)
5/6 (83.33%)
$7.15 (7.70%)
448
Which stock is Prakhar Agrawal is most bullish on?
What Year was the first public recommendation made by Prakhar Agrawal?
